Biosimilars and the European Experience: Implications for the United States

Francis Megerlin (), Ruth Lopert, Ken Taymor and Jean-Hugues Trouvin
Additional contact information
Francis Megerlin: GRADES - Groupe de Recherche et d'Accueil en Droit et Economie de la Santé - Université Paris-Saclay
Ruth Lopert: GWU - Georges Washington University
Ken Taymor: UC Berkeley - University of California [Berkeley] - UC - University of California

Post-Print from HAL

Date: 2013
References: Add references at CitEc
Citations:

Published in Health Affairs, 2013, 32 (10), pp.1803-1810

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-04180556

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().